Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) Reports Fourth Quarter Financial Results and Reaffirms 2013 Financial Guidance

Published: Mar 01, 2013

MALVERN, Pa., Feb. 28, 2013 /PRNewswire/ --

•Total quarterly revenues of $801 million, comparable to prior year.
•Fourth quarter reported diluted (GAAP) loss per share of $6.35 includes a $640 million non-cash asset impairment charge related primarily to goodwill and other intangible assets attributable to the company's American Medical Systems (AMS) segment.
•Fourth quarter adjusted diluted EPS of $1.62 increased by 16 percent versus prior year; Full year 2012 adjusted diluted EPS of $5.02 was in-line with financial guidance.

Back to news